BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22904134)

  • 41. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
    Lin Q; Chen T; Lin Q; Lin G; Lin J; Chen G; Guo L
    J Surg Oncol; 2013 Jun; 107(7):767-71. PubMed ID: 23609137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of RIN1 gene expression in human non-small cell lung cancer.
    Wang Q; Gao Y; Tang Y; Ma L; Zhao M; Wang X
    Acta Histochem; 2012 Sep; 114(5):463-8. PubMed ID: 21925717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
    Xu YH; Lu S
    Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival.
    Caputi M; Esposito V; Baldi A; De Luca A; Dean C; Signoriello G; Baldi F; Giordano A
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):213-7. PubMed ID: 9476908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer.
    Sanmartín E; Sirera R; Usó M; Blasco A; Gallach S; Figueroa S; Martínez N; Hernando C; Honguero A; Martorell M; Guijarro R; Rosell R; Jantus-Lewintre E; Camps C
    Ann Surg Oncol; 2014 Feb; 21(2):612-20. PubMed ID: 24145997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.
    Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
    Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
    Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P
    Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma.
    Wan L; Huang J; Chen J; Wang R; Dong C; Lu S; Wu X
    J BUON; 2015; 20(1):188-95. PubMed ID: 25778315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer.
    Ni S; Xu L; Huang J; Feng J; Zhu H; Wang G; Wang X
    Int J Clin Exp Pathol; 2013; 6(12):2887-95. PubMed ID: 24294375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of Zinc Finger Homeobox 3 expression in tumor cells decreases the survival rate among non-small cell lung cancer patients.
    Minamiya Y; Saito H; Ito M; Imai K; Konno H; Takahashi N; Motoyama S; Ogawa J
    Cancer Biomark; 2012; 11(4):139-46. PubMed ID: 23144151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
    Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
    Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
    Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer.
    Kong PZ; Li GM; Tian Y; Song B; Shi R
    Oncotarget; 2016 Aug; 7(34):55601-55610. PubMed ID: 27487137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion.
    Chen P; Li K; Liang Y; Li L; Zhu X
    Exp Lung Res; 2013 Feb; 39(1):9-17. PubMed ID: 23215946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.
    Micke P; Edlund K; Holmberg L; Kultima HG; Mansouri L; Ekman S; Bergqvist M; Scheibenflug L; Lamberg K; Myrdal G; Berglund A; Andersson A; Lambe M; Nyberg F; Thomas A; Isaksson A; Botling J
    J Thorac Oncol; 2011 Nov; 6(11):1833-40. PubMed ID: 22011649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer.
    Liu L; Zhao E; Li C; Huang L; Xiao L; Cheng L; Huang X; Song Y; Xu D
    Cancer Epidemiol; 2013 Feb; 37(1):71-8. PubMed ID: 22959342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.
    Dziadziuszko R; Merrick DT; Witta SE; Mendoza AD; Szostakiewicz B; Szymanowska A; Rzyman W; Dziadziuszko K; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR
    J Clin Oncol; 2010 May; 28(13):2174-80. PubMed ID: 20351332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
    Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
    Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
    Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
    Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
    Ramnath N; Hernandez FJ; Tan DF; Huberman JA; Natarajan N; Beck AF; Hyland A; Todorov IT; Brooks JS; Bepler G
    J Clin Oncol; 2001 Nov; 19(22):4259-66. PubMed ID: 11709570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.